French deal volume in 2022 remained at historic levels, even while deal values dipped in the final quarter of the year
France’s M&A market had a solid run of deal activity in 2022 and continues to demonstrate resilience....more
After reaching unprecedented highs in 2021, global M&A markets had a bumpy ride in 2022 as dealmakers grappled with inflation, rising interest rates and fallout from the conflict in Ukraine.
Deal value for 2022 came in...more
Global dealmaking was consistently strong in 2021, with the value topping US$1 trillion in each quarter for the first time on record. This achievement is particularly impressive given the tumultuous deal environment, as M&A...more
Dealmaking within the PMB sector enjoyed an impressive start as companies across the globe embarked on their post-pandemic recovery -
The global pharma, medical and biotech (PMB) sector saw US$95.4 billion in deal...more